In Massachusetts Institute of Technology v. Shire Pharmaceuticals, Inc., Appeal No. 2015-1881, the Federal Circuit affirmed the district court’s conclusion that a clear and unmistakable prosecution disclaimer had not occurred... read more →
In Poly-America, L.P. v. API Industries, Inc., Appeal No. 2016-1200, the Federal Circuit affirmed a narrow claim construction based on a “clear and unequivocal” disavowal of claim scope in the... read more →
In FairWarning IP, LLC v. Iatric Systems, Inc., Appeal No. 2015-1985, the Federal Circuit affirmed the district court’s holding that FairWarning’s patent claimed patent-ineligible subject matter under 35 U.S.C. §... read more →
In In Re: Constantin Efthymiopoulos, Appeal No. 2016-1003, the Federal Circuit affirmed the Patent Trial and Appeal Board’s decision affirming the Examiner’s rejection of all pending claims as obvious. Applicant... read more →
In Medtronic, Inc. v. Robert Bosch Healthcare Systems, Inc., Appeal Nos. 2015-1977, 2015-1986, 2015-1987, the Federal Circuit ruled that a Patent Trial and Appeal Board determination to vacate an institution... read more →